Found: 10
Select item for more details and to access through your institution.
Effect of Levodopa-carbidopa Intestinal Gel on Non-motor Symptoms in Patients with Advanced Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 6, p. 829, doi. 10.1002/mdc3.12526
- By:
- Publication type:
- Article
Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation.
- Published in:
- Pharmacology Research & Perspectives, 2019, v. 7, n. 2, p. 1, doi. 10.1002/prp2.473
- By:
- Publication type:
- Article
Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson's Disease Receiving ≥2000 mg Daily Dose of Levodopa.
- Published in:
- Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/9716317
- By:
- Publication type:
- Article
Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety.
- Published in:
- Clinical Pharmacokinetics, 2015, v. 54, n. 9, p. 975, doi. 10.1007/s40262-015-0265-3
- By:
- Publication type:
- Article
Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson's disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756286418759315
- By:
- Publication type:
- Article
Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reply to letter: Suicide in Parkinson's disease patients treated with levodopa-carbidopa Intestinal Gel.
- Published in:
- Movement Disorders, 2015, v. 30, n. 10, p. 1435, doi. 10.1002/mds.26316
- By:
- Publication type:
- Article
Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: Final 12-month, open-label results.
- Published in:
- Movement Disorders, 2015, v. 30, n. 4, p. 500, doi. 10.1002/mds.26123
- By:
- Publication type:
- Article